Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Esophagitis × avasopasem manganese × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Stomatitis 2 Squamous Cell Carcinoma of Head and Neck 1 Pancreatic Neoplasms 1 Head and Neck Neoplasms 1 Esophagitis 1 Disease Progression 1

Interventions

avasopasem manganese 1 Surgical Procedures, Operative 1 Radiation 1 Induction Chemotherapy 1 Heart Rate 1 Gastropexy 1 Fundoplication 1 Esomeprazole 1 Endoscopy, Digestive System 1 Drug Therapy 1 Dietary Supplements 1 Amifostine 1 Alginates 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04225026 2023-03-23

Effects of Intravenous GC4419 on the Incidence and Severity of Esophagitis Due to Chemoradiotherapy for Lung Cancer

Galera Therapeutics, Inc.

Phase 2 Terminated

39 enrolled 12 charts

Esophagitis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡